Pharmacy

Keyphrases

1. Pharmacist 100%
2. Healthcare Professionals 53%
3. Adverse Drug Reaction 50%
4. Primary Care 49%
5. Community Pharmacists 44%
6. Randomized Controlled Trial 43%
7. Cancer Cells 42%
8. Systematic Meta-analysis 39%
9. Pharmacy 38%
10. Meta-analysis 37%
11. Community Pharmacy 36%
12. Alzheimer's Disease 35%
13. Anticancer Complexes 33%
14. Blood Pressure 31%
15. United Kingdom 31%
16. Antiproliferative Activity 31%
17. Cisplatin 30%
18. In Cancer 29%
19. Prescribers 29%
20. Pediatric 29%
21. Carbon Nanotubes 29%
22. People Experiencing Homelessness 29%
23. Antipsychotics 27%
24. Mechanism of Action 27%
25. Electronic Prescribing System 26%
26. Medication Errors 26%
27. A2780 26%
28. Pharmacist Intervention 26%
29. General Practice 26%
30. Nanoparticles 25%
31. Embase 25%
32. Medication Adherence 25%
33. Half-sandwich 25%
34. Pediatric Population 24%
35. COVID-19 Pandemic 24%
36. Anticancer Activity 24%
37. Clinical Outcomes 24%
38. MEDLINE 23%
39. Ca2+ 22%
40. Small Molecules 22%
41. Hospital Setting 22%
42. COVID-19 22%
43. Pharmacology 22%
44. 5-hydroxytryptamine 22%
45. Clinical Trials 21%
46. Hypertension 21%
47. Hospital Admission 20%
48. Direct Oral Anticoagulants 20%
49. Human Ovarian Cancer Cell 20%
50. Saudi Arabia 19%
51. Non-adherence 19%
52. Organo 18%
53. Mixed-methods Study 18%
54. Nanomaterials 18%
55. Cytotoxicity 18%
56. Patients with Diabetes 18%
57. Healthcare 18%
58. Secondary Care 17%
59. Clinical Pharmacist 17%
60. Glycomimetics 17%
61. Emergency Department 17%
62. Wales 17%
63. Theoretical Domains Framework 17%
64. Inflammation 17%
65. Drug Discovery 17%
66. Suspected Adverse Drug Reactions 17%
67. Confidence Interval 17%
68. 5-HT3 Receptor 17%
69. Osmium 16%
70. Dopamine 16%
71. Cardiovascular Disease 16%
72. Spray-dried Powder 16%
73. Prescribing Errors 16%
74. Lung 16%
75. IC50 16%
76. Pharmacist Role 16%
77. Nerve Terminal 16%
78. Homelessness 16%
79. Pharmacist Attitudes 16%
80. Multi-target 15%
81. Hospitalized Patients 15%
82. Contributory Factors 15%
83. Transfer Hydrogenation 15%
84. Physicochemical Properties 15%
85. Clinical Decision Support 15%
86. Systematic Literature Review 15%
87. Diabetes 15%
88. Hypertension Diagnosis 14%
89. Risk Factors 14%
90. Multi-walled Carbon Nanotubes (MWCNTs) 14%
91. Ambulatory Blood Pressure Monitoring 14%
92. Medicine Use 14%
93. EPrescribing 14%
94. Antibiotics 14%
95. Amino Acids 14%
96. Prescription Drugs 14%
97. Drug Delivery 14%
98. Amyotrophic Lateral Sclerosis 14%
99. Hydrogenation Catalyst 14%
100. Molecular Dynamics 13%